# FDA 483 - Novartis Pharma Stein AG - September 21, 2018

Source: https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/c1a50ba5-5c14-4501-b8a8-c0f7c3846768

> FDA 483 for Novartis Pharma Stein AG on September 21, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Novartis Pharma Stein AG
- Inspection Date: 2018-09-21
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/f3a9e3a5-6a24-4cee-8828-d04febb3157a)
- [483 - 2017-05-09](https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/7b86250e-44fe-421e-b1e3-1bbe8eff4a22)
- [483 - 2022-12-06](https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/40f6d9f7-2240-457c-a48f-383274c1bcf0)
- [483 - 2017-05-09](https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/744bc0b9-9ae9-4b95-8ef6-c6abe8b8f1c6)
- [483 - 2018-12-04](https://www.globalkeysolutions.net/records/483/novartis-pharma-stein-ag/3e713a20-3bd1-4991-aad5-bac1eccc2725)

## Related Officers

- [Anjali Shukla](https://www.globalkeysolutions.net/people/anjali-shukla/23e50484-91bf-436f-971e-2efd3c2b3d0a)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd